REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaxosmithkline Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Glaxosmithkline Ecuador S.A. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

GlaxoSmithKline Ecuador S.A. is the Ecuador affiliate of GSK, a global healthcare and pharmaceutical company. It generates revenue from sales of prescription medicines, vaccines and consumer healthcare products. Positioned within the healthcare value chain, it supplies regulated pharmaceuticals to providers and pharmacies, facing stringent compliance and market competition.

Headquarters
Av. 6 de Diciembre, E10-A
Quito; Pichincha;

Contact Details: Purchase the Glaxosmithkline Ecuador S.A. report to view the information.

Website: http://www.gsk.com

Basic Information
Total Employees:
Purchase the Glaxosmithkline Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Glaxosmithkline Ecuador S.A. report to view the information.
Financial Auditors:
Purchase the Glaxosmithkline Ecuador S.A. report to view the information.
Incorporation Date:
September 21, 1984
Key Executives
Purchase this report to view the information.
Commercial Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Glaxosmithkline Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-21.52%
Total Operating Revenue
-21.52%
Operating Profit
23.63%
EBITDA
16.18%
Net Profit/Loss for the Period
-3.42%
Total Assets
3.47%
Total Equity
4.65%
Operating Profit Margin
2.03%
Net Profit Margin
1.05%
Return on Equity (ROE)
-0.38%
Debt / Equity
-4.44%
Quick Ratio
0.36%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?